Terns Pharmaceuticals Stock Performance in March
This article analyzes the reasons behind Terns Pharmaceuticals stock's significant market performance during the month of March.
Results for "Terns Pharmaceuticals"
4 stories found
Analyst Optimistic on Terns Pharmaceuticals' Upcoming Leukemia Drug
An analyst expresses optimism regarding Terns Pharmaceuticals (TERN) and its upcoming leukemia drug, projecting a potential market value of $4.8 billion for the treatment.
Merck Finalizes $6B Terns Pharma Acquisition; Investors Question Premium
Merck has finalized its acquisition of Terns Pharmaceuticals for nearly $6 billion to boost its cancer drug pipeline, though analysts and investors are now questioning the premium paid for the deal.
Merck Finalizes Nearly $6 Billion Acquisition of Cancer Biotech Terns
Merck has finalized its acquisition of Terns Pharmaceuticals for nearly $6 billion, aiming to boost its cancer drug pipeline following promising clinical data on a bone and blood cancer treatment.